CAI Stock Analysis: Buy, Sell, or Hold?
CAI - Caris Life Sciences, Inc. Common Stock
$18.30
-0.45 (-2.40%)
▼
5d:
-2.14%
30d:
+10.77%
90d:
-4.34%
BUY
HIGH Confidence
Analysis Updated: Jul 2, 2026 12:00 AM ET
Earnings: Aug 11, 2026
Get Alerted When CAI Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: CAI shows strong fundamentals and good volume confirmation. Solid entry point despite slightly high pricing.
✅ BUY SIGNAL: CAI shows strong fundamentals and good volume confirmation. Solid entry point despite slightly high pricing.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$17.80
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$11.05
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: CAI is currently trading at $18.30, which is considered slightly high relative to its 30-day fair value range of $16.36 to $18.35. The stock's valuation (Forward PE: 50.0) is in line with its historical norms (48.7). At these levels, the market is pricing in 0.9% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, CAI is in a downtrend. Immediate support is located at $16.82, while resistance sits at $19.97.
Market Sentiment: CAI has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $27.83 (+52.1%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, CAI is in a downtrend. Immediate support is located at $16.82, while resistance sits at $19.97.
Market Sentiment: CAI has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $27.83 (+52.1%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Historical Trading Range
$16.36 -
$18.35
Company Quality Score
62/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
77.1%
All Signals
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 52.1% below Wall St target ($27.83)
- NEUTRAL: Market pricing in 0.9% annual earnings growth - fairly valued
Trading Range Analysis
30-Day Trading Range
$16.36 -
$18.35
Current vs Trading Range
SLIGHTLY HIGH
Support & Resistance Levels
Support Level
$16.82
Resistance Level
$19.97
Current Trend
Downtrend
Technical data as of
Jul 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
50.04
Wall Street Target
$27.83
(+52.1%)
Revenue Growth (YoY)
78.8%
Profit Margin
3.8%
Valuation Premium vs History
+0.9% premium
PE vs Historical
50.0 vs 48.7
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+0.9%
(market-implied from PE analysis)
1-Year Target
$18.46
(+1%)
2-Year Target
$18.63
(+2%)
3-Year Target
$18.80
(+3%)
3-Yr Target (if PE normalizes)
(PE: 50→49)
PE COMPRESSION
$18.29
(0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 50.0, Growth: 175.2%)
$61.76
(+238%)
Base:
(SPY PE: 21.8, Growth: 175.2%)
$26.88
(+47%)
Bear:
(PE: 18.5, Growth: 175.2%)
$22.85
(+25%)
Share & Embed Analysis
Last updated: July 04, 2026 5:44 AM ET
Data refreshes hourly during market hours. Next update: 6:43 AM
Data refreshes hourly during market hours. Next update: 6:43 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CAI showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NTLA
Intellia Therapeutics Inc |
STRONG BUY
29 analysts |
$27 | 55 HOLD |
|
ONC
BeiGene, Ltd. |
STRONG BUY
24 analysts |
$412 | 59 HOLD |
|
REGN
Regeneron Pharmaceutical… |
STRONG BUY
25 analysts |
$833 | 63 BUY |
|
INSM
Insmed Inc |
STRONG BUY
21 analysts |
$197 | 54 HOLD |
|
VKTX
Viking Therapeutics Inc |
STRONG BUY
19 analysts |
$93 | 63 BUY |